Rocket Pharma officer plans sale of 631 shares

ROCKET PHARMACEUTICALS, INC.

Rhea-AI Filing Summary

ROCKET PHARMACEUTICALS, INC. (RCKT) is the issuer for a planned resale of common stock under Rule 144 for the account of officer Martin Wilson. A notice was filed for the potential sale of 631 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $2,133.66 as of 08/18/2026 on NASDAQ. The shares derive from restricted stock vesting on 08/14/2026 and are characterized as compensation. In the prior three months, Wilson reported sales of 662 shares for $1,995.53 on 05/19/2026 and 3,493 shares for $11,810.18 on 08/13/2026. The filer notes that the sale includes shares to cover a tax obligation from the settlement of a vested equity award.

Key Figures

Planned shares to be sold: 631 shares Aggregate market value of planned sale: $2,133.66 Past sale on 05/19/2026: 662 shares for $1,995.53 +2 more

5 metrics

Planned shares to be sold 631 shares Common stock under Rule 144 for Martin Wilson

Aggregate market value of planned sale $2,133.66 Value for 631 shares as of 08/18/2026

Past sale on 05/19/2026 662 shares for $1,995.53 Common stock sold by Martin Wilson in prior 3 months

Past sale on 08/13/2026 3,493 shares for $11,810.18 Common stock sold by Martin Wilson in prior 3 months

Vesting date of restricted stock 08/14/2026 Source of shares noted as Restricted Stock Vesting

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 08/14/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Martin Wilson"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

aggregate market value financial

"631 | 2133.66 | 109774597 | 08/18/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for ROCKET PHARMACEUTICALS, INC. (RCKT)?

The Form 144 reports a planned resale of 631 RCKT common shares by officer Martin Wilson under Rule 144. It is a disclosure of a potential sale of restricted shares, not an offering by Rocket Pharmaceuticals itself.

How many RCKT shares are planned to be sold under this Rule 144 notice?

The notice covers a potential sale of 631 common shares of RCKT. These shares are to be sold through Fidelity Brokerage Services LLC and are tied to restricted stock vesting dated 08/14/2026.

What is the reported market value of the RCKT shares covered by this Form 144?

The 631 RCKT shares covered by the notice have an aggregate market value of $2,133.66 as of 08/18/2026. This figure is disclosed in connection with the planned sale on NASDAQ.

What RCKT share sales has Martin Wilson reported in the past three months?

Martin Wilson reported selling 662 RCKT shares for $1,995.53 on 05/19/2026 and 3,493 shares for $11,810.18 on 08/13/2026. These prior transactions are disclosed as required for aggregation under Rule 144.

Why does the filing mention tax obligations related to RCKT equity awards?

The filer explains that the planned sale includes shares to cover a tax obligation arising from settlement of a vested equity award. This links the Rule 144 sale to compensation-related restricted stock vesting for Martin Wilson.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 03:47 PM EDT Accepted by SEC EDGAR 08/18/2026 - 03:47 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001704342
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROCKET PHARMACEUTICALS, INC.
SEC File Number	001-36829
Address of Issuer	350 FIFTH AVENUE SUITE 7530 NEW YORK NEW YORK 10118
Phone	646-440-9100
Name of Person for Whose Account the Securities are To Be Sold	Wilson Martin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	631	2133.66	109774597	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/14/2026	Restricted Stock Vesting	Issuer			631	08/14/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martin Wilson 9 Cedarbrook Drive Cranbury NJ 08512	Common	05/19/2026	662	1995.53
Martin Wilson 9 Cedarbrook Drive Cranbury NJ 08512	Common	08/13/2026	3493	11810.18

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Martin Wilson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)